FY2025 EPS Estimates for Waters Lifted by Leerink Partnrs

Waters Corporation (NYSE:WAT) – Investment analysts at Leerink Partnrs raised their FY2025 EPS estimates for Waters in a research note issued on Tuesday, November 4th. Leerink Partnrs analyst P. Souda now forecasts that the medical instruments supplier will earn $13.11 per share for the year, up from their previous forecast of $13.00. The consensus estimate for Waters’ current full-year earnings is $12.86 per share. Leerink Partnrs also issued estimates for Waters’ Q4 2025 earnings at $4.51 EPS, Q1 2026 earnings at $2.61 EPS, Q2 2026 earnings at $3.29 EPS, Q3 2026 earnings at $3.34 EPS, Q4 2026 earnings at $4.97 EPS and FY2026 earnings at $14.21 EPS.

Waters (NYSE:WAT) last issued its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. The firm had revenue of $608.55 million for the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%.

Several other brokerages have also recently weighed in on WAT. Redburn Partners set a $390.00 price objective on shares of Waters in a research note on Wednesday, October 8th. Rothschild Redb upgraded shares of Waters to a “strong-buy” rating in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft set a $315.00 target price on shares of Waters and gave the stock a “hold” rating in a report on Tuesday, August 5th. Robert W. Baird cut their target price on shares of Waters from $374.00 to $352.00 and set an “outperform” rating on the stock in a report on Wednesday, July 16th. Finally, Wall Street Zen lowered shares of Waters from a “buy” rating to a “hold” rating in a report on Saturday, July 26th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $381.57.

Waters Price Performance

Shares of Waters stock opened at $372.09 on Thursday. The company has a current ratio of 1.75, a quick ratio of 1.22 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $22.15 billion, a price-to-earnings ratio of 33.55, a P/E/G ratio of 3.19 and a beta of 1.11. Waters has a 1-year low of $275.05 and a 1-year high of $423.56. The firm’s 50-day moving average price is $320.65 and its two-hundred day moving average price is $325.41.

Institutional Investors Weigh In On Waters

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Swedbank AB boosted its holdings in shares of Waters by 25.8% during the 2nd quarter. Swedbank AB now owns 40,526 shares of the medical instruments supplier’s stock worth $14,145,000 after buying an additional 8,305 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Waters by 5.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 530,697 shares of the medical instruments supplier’s stock worth $195,599,000 after purchasing an additional 28,018 shares in the last quarter. Jacobs Levy Equity Management Inc. acquired a new stake in Waters in the 1st quarter worth about $1,244,000. Mn Services Vermogensbeheer B.V. raised its stake in Waters by 7.0% in the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 22,933 shares of the medical instruments supplier’s stock worth $8,005,000 after purchasing an additional 1,500 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its stake in Waters by 12.6% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,021 shares of the medical instruments supplier’s stock worth $2,800,000 after purchasing an additional 896 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.